Chemoinformaics analysis of 2-(Methylamino)benzaldehyde
Molecular Weight | 135.166 | nRot | 2 |
Heavy Atom Molecular Weight | 126.094 | nRig | 7 |
Exact Molecular Weight | 135.068 | nRing | 1 |
Solubility: LogS | -2.551 | nHRing | 0 |
Solubility: LogP | 1.772 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 21.2631 |
nHD | 1 | BPOL | 10.4669 |
QED | 0.623 |
Synth | 2.01 |
Natural Product Likeliness | -0.341 |
NR-PPAR-gamma | 0.047 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.007 |
HIA | 0.009 |
CACO-2 | -4.495 |
MDCK | 0.0000264 |
BBB | 0.959 |
PPB | 0.661392 |
VDSS | 1.373 |
FU | 0.342714 |
CYP1A2-inh | 0.931 |
CYP1A2-sub | 0.609 |
CYP2c19-inh | 0.289 |
CYP2c19-sub | 0.572 |
CYP2c9-inh | 0.137 |
CYP2c9-sub | 0.816 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.797 |
CYP3a4-inh | 0.054 |
CYP3a4-sub | 0.163 |
CL | 8.047 |
T12 | 0.779 |
hERG | 0.016 |
Ames | 0.317 |
ROA | 0.041 |
SkinSen | 0.75 |
Carcinogencity | 0.202 |
EI | 0.992 |
Respiratory | 0.974 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.887946 |